150 related articles for article (PubMed ID: 37513899)
1. The Carnitine Palmitoyltransferase 1A Inhibitor Teglicar Shows Promising Antitumour Activity against Canine Mammary Cancer Cells by Inducing Apoptosis.
Cacciola NA; Sepe F; Fioriniello S; Petillo O; Margarucci S; Scivicco M; Peluso G; Balestrieri A; Bifulco G; Restucci B; Severino L
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513899
[TBL] [Abstract][Full Text] [Related]
2. Carnitine palmitoyltransferase 1 A expression profile in canine mammary tumors.
Cacciola NA; Sgadari M; Petillo O; Margarucci S; Martano M; Cocchia N; Maiolino P; Restucci B
Vet J; 2020 Mar; 257():105453. PubMed ID: 32546357
[TBL] [Abstract][Full Text] [Related]
3. Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis.
Conti R; Mannucci E; Pessotto P; Tassoni E; Carminati P; Giannessi F; Arduini A
Diabetes; 2011 Feb; 60(2):644-51. PubMed ID: 21270274
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Flexibility in Canine Mammary Tumors: Implications of the Carnitine System.
Cacciola NA; Sgadari M; Sepe F; Petillo O; Margarucci S; Martano M; Maiolino P; Restucci B
Animals (Basel); 2021 Oct; 11(10):. PubMed ID: 34679988
[TBL] [Abstract][Full Text] [Related]
5. Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells.
Gelaleti GB; Borin TF; Maschio-Signorini LB; Moschetta MG; Hellmén E; Viloria-Petit AM; Zuccari DAPC
Vet Comp Oncol; 2017 Dec; 15(4):1572-1584. PubMed ID: 28322030
[TBL] [Abstract][Full Text] [Related]
6. Effect of the VP3 gene of chicken anemia virus on canine mammary tumor cells.
Lee JJ; Chen PB; Yang SH; Cheng CH; Chueh LL; Pang VF; Hsiao M; Lin CT
Am J Vet Res; 2007 Apr; 68(4):411-22. PubMed ID: 17397298
[TBL] [Abstract][Full Text] [Related]
7. In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD-0332991) for treating canine mammary tumours.
Schoos A; Knab VM; Gabriel C; Tripolt S; Wagner DA; Bauder B; Url A; Fux DA
Vet Comp Oncol; 2019 Dec; 17(4):507-521. PubMed ID: 31207004
[TBL] [Abstract][Full Text] [Related]
8. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
[TBL] [Abstract][Full Text] [Related]
9. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
10. Chemically modified tetracyclines induce apoptosis in cultured mast cells.
Sandler C; Nurmi K; Lindstedt KA; Sorsa T; Golub LM; Kovanen PT; Eklund KK
Int Immunopharmacol; 2005 Oct; 5(11):1611-21. PubMed ID: 16039551
[TBL] [Abstract][Full Text] [Related]
11. Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.
Pucci S; Zonetti MJ; Fisco T; Polidoro C; Bocchinfuso G; Palleschi A; Novelli G; Spagnoli LG; Mazzarelli P
Oncotarget; 2016 Apr; 7(15):19982-96. PubMed ID: 26799588
[TBL] [Abstract][Full Text] [Related]
12. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
13. Effects of Tyrosine Kinase Inhibitor-masitinib Mesylate on Canine Mammary Tumour Cell Lines.
Ustun-Alkan F; Bakırel T; Üstüner O; Anlas C; Cinar S; Yıldırım F; Gürel A
J Vet Res; 2021 Sep; 65(3):351-359. PubMed ID: 34917849
[TBL] [Abstract][Full Text] [Related]
14. Carnitine-acyltransferase system inhibition, cancer cell death, and prevention of myc-induced lymphomagenesis.
Pacilli A; Calienni M; Margarucci S; D'Apolito M; Petillo O; Rocchi L; Pasquinelli G; Nicolai R; Koverech A; Calvani M; Peluso G; Montanaro L
J Natl Cancer Inst; 2013 Apr; 105(7):489-98. PubMed ID: 23486551
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
[TBL] [Abstract][Full Text] [Related]
16. Optically active stereoisomers of 5-(1-iodoethyl)-4-(4'-isopropylphenyl)dihydrofuran-2-one: The effect of the configuration of stereocenters on apoptosis induction in canine cancer cell lines.
Pawlak A; Gładkowski W; Mazur M; Henklewska M; Obmińska-Mrukowicz B; Rapak A
Chem Biol Interact; 2017 Jan; 261():18-26. PubMed ID: 27867085
[TBL] [Abstract][Full Text] [Related]
17. Antitumor Effects of Esculetin, a Natural Coumarin Derivative, against Canine Mammary Gland Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.
Choi J; Yoo MJ; Park SY; Seol JW
Vet Sci; 2023 Jan; 10(2):. PubMed ID: 36851388
[TBL] [Abstract][Full Text] [Related]
18. The Reversible Carnitine Palmitoyltransferase 1 Inhibitor (Teglicar) Ameliorates the Neurodegenerative Phenotype in a Drosophila Huntington's Disease Model by Acting on the Expression of Carnitine-Related Genes.
Bertapelle C; Carillo MR; Cacciola NA; Shidlovskii YV; Peluso G; Digilio FA
Molecules; 2022 May; 27(10):. PubMed ID: 35630602
[TBL] [Abstract][Full Text] [Related]
19. Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds.
Raposo LR; Roma-Rodrigues C; Jesus J; Martins LMDRS; Pombeiro AJ; Baptista PV; Fernandes AR
Vet Comp Oncol; 2017 Dec; 15(4):1537-1542. PubMed ID: 28150469
[TBL] [Abstract][Full Text] [Related]
20. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
